Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP429576.RAh3EUXuYj29S73traRFowdu_1CVKGf6eK8AF8cQOKlA0130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429576.RAh3EUXuYj29S73traRFowdu_1CVKGf6eK8AF8cQOKlA0130_provenance.
• NP238079.RA587vinNYW5DbKg2jOnysMeIJn9ORuGLSB-e63vjtw2o130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238079.RA587vinNYW5DbKg2jOnysMeIJn9ORuGLSB-e63vjtw2o130_provenance.
• NP725486.RA4tZzgRRKmrrVX78-qXeCuN5nCcqENKngOb6whP0-6rw130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725486.RA4tZzgRRKmrrVX78-qXeCuN5nCcqENKngOb6whP0-6rw130_provenance.
• NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
• NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847322.RA4LXe4HIs5YJcEOjJoiuPMkUg8C-BlAyyiCfZDoGziTA130_provenance.
• NP795532.RAT6UdVgHY56IoEQfnORXJLdxUVc4Opoj0nAFOs4GHpyU130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795532.RAT6UdVgHY56IoEQfnORXJLdxUVc4Opoj0nAFOs4GHpyU130_provenance.
• NP562479.RALBuQryyVF-3C1fmD1VFXp8eHQyKj-AE7OLeNpg1Sy-4130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562479.RALBuQryyVF-3C1fmD1VFXp8eHQyKj-AE7OLeNpg1Sy-4130_provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP786428.RAC6eQS-dCyh5vgwwdUtitwgKDcy6ITMJEGKgmjeSm5EQ130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786428.RAC6eQS-dCyh5vgwwdUtitwgKDcy6ITMJEGKgmjeSm5EQ130_provenance.
• NP998062.RAAXg8B5PNfgWn7rq9Zn3pPUNoB1p8wi1Vk6CA4w9xYzQ130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998062.RAAXg8B5PNfgWn7rq9Zn3pPUNoB1p8wi1Vk6CA4w9xYzQ130_provenance.
• NP786418.RAhdzM8kk8ht6QKG2SGcOKfLWZPlm5V6dBPcW2vmdbMiI130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786418.RAhdzM8kk8ht6QKG2SGcOKfLWZPlm5V6dBPcW2vmdbMiI130_provenance.
• NP998066.RAqAHxSnDRqFu54XbjTmIXOGN2D5qlmzd2s5tDo54tJw0130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998066.RAqAHxSnDRqFu54XbjTmIXOGN2D5qlmzd2s5tDo54tJw0130_provenance.
• NP627878.RAMLFobb1p6eeBI2UY2QxOT0PJBcbAddcRGWRps4PRcMA130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627878.RAMLFobb1p6eeBI2UY2QxOT0PJBcbAddcRGWRps4PRcMA130_provenance.
• NP998060.RAL3gmwUSTTJ0j1ntOjhYr2GmUqxp8yNNyJ-GJcYBIJKk130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998060.RAL3gmwUSTTJ0j1ntOjhYr2GmUqxp8yNNyJ-GJcYBIJKk130_provenance.
• NP998067.RAPUN5YrLkzVhnsKLx04cEY69QIQvcH2DaYa_s1cFNS8Y130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998067.RAPUN5YrLkzVhnsKLx04cEY69QIQvcH2DaYa_s1cFNS8Y130_provenance.
• NP795535.RA5KGN-IMKkTlamKRwESVWE2nljx2eZKiOCwa2VxS-ssg130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795535.RA5KGN-IMKkTlamKRwESVWE2nljx2eZKiOCwa2VxS-ssg130_provenance.
• NP998056.RAyIJ0uvUcJaTjC8_SHyjXuNDNrrPE5AIq4CH9RzVyPDc130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998056.RAyIJ0uvUcJaTjC8_SHyjXuNDNrrPE5AIq4CH9RzVyPDc130_provenance.
• NP998064.RA9zDp7e23LUYHf1URxR_M2SaqRFSsePaaG5maSu0NZPg130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998064.RA9zDp7e23LUYHf1URxR_M2SaqRFSsePaaG5maSu0NZPg130_provenance.